Country Oncology Lead– Commercial Oncology

المسمى الوظيفي

411_3311733

Overview

Designation: Country Oncology Lead – Commercial Oncology

Business Unit: Oncology

Function: Commercial (Sales, Marketing & Business Operations)

Location: UAE/Flexible

Reporting to: Country General Manager and dotted line reporting to Global Oncology Head

Role Overview/Purpose:

This is a foundational, build-from-the-ground-up leadership role responsible for establishing Glenmark as a credible and competitive oncology player in a priority launch market.

The Country Oncology BUD will have end-to-end responsibility for the commercial launch and growth of Glenmark’s first innovative oncology assets in-country, including immuno-oncology, antibody–drug conjugates (ADCs), and targeted therapies (EGFR TKIs).

With the first launch planned in <12 months, the role demands a leader who can simultaneously design strategy and execute hands-on, building the organization, shaping the go-to-market model, and ensuring flawless launch readiness — all while partnering closely with the Country GM and Global Oncology teams.

This role combines:

• Strategic leadership
• Operational intensity
• External oncology credibility
• A true “general manager mindset” within oncology

Overall Job Responsibilities:

المهام الأساسية

1. Country Oncology Strategy & Financial Accountability
   • Define and lead the country oncology commercial strategy, fully aligned with global oncology franchise priorities and local market realities.
   • Be accountable for oncology revenue and gross margin delivery, with shared P&L ownership alongside the Country General Manager.
   • Develop robust forecasts, business plans, and scenario models to support investment decisions. Represent oncology performance, risks, and opportunities at the Country Leadership Team and to Global Oncology leadership.
2. Launch Excellence & Execution Leadership
   • Own end-to-end launch readiness for first-in-country innovative oncology assets.
   • Lead integrated launch planning across: Marketing strategy and execution; Market access coordination; Supply and demand planning.
   • Establish clear launch KPIs, uptake milestones, and post-launch optimization plans.
   • Ensure best-in-class execution for IO, ADC, and targeted therapy launches in a highly competitive environment.
3. Organization Build & Commercial Capability Creation
   • Build the oncology organization from near-zero, including: Sales, Marketing, Business Operations.
   • Define optimal field force size, structure, and deployment model.
   • Recruit, develop, and retain high-caliber oncology talent with a strong performance culture.
   • Instill strong governance, compliance, and execution discipline from day one.
   • Design differentiated go-to-market models tailored to tumor types, treatment settings, and customer segments.
   • Pricing and access strategy (in collaboration with access/medical)
   • Promotional excellence
   • Omnichannel customer engagement
   • Drive strong performance of in-line products while preparing the organization for pipeline expansion.
4. External Stakeholder & Oncology Ecosystem Leadership
   • Act as the senior commercial face of Glenmark Oncology in-country.
   • Build strong relationships with: Key opinion leaders (KOLs) and Oncology societies and networks; Strategic partners and distributors (if applicable).
   • Partner closely with Medical Affairs on scientific engagement and disease-area shaping.
   • Support business development, licensing, and alliance activities where relevant at country level.

Key Relationships/Stakeholders:

External

• Oncology KOLs and treatment centers
• Oncology societies and networks
• Strategic partners and service providers

Internal (other than Direct Reports)

• Country General Manager and Country Leadership Team
• Global Oncology Franchise & Brand Teams
• Country Medical Affairs, Market Access, Regulatory, Finance, and Supply Chain

Desired Experience and Knowledge:

Educational Knowledge:

• MBA or master’s degree in business, Life Sciences, or related field preferred

الخبرة:

• 12–15+ years of pharmaceutical / biotech experience, with a strong focus on innovative oncology.
• Proven track record of launching first-in-country innovative oncology products, ideally in solid tumors.
• Direct experience across IO, ADCs, and/or targeted therapies (e.g., EGFR TKIs).
• Demonstrated success in building and leading oncology teams from scratch or early stage.
• Experience operating in complex, fast-evolving oncology markets.
• Prior country-level or franchise leadership experience is strongly preferred.

Knowledge and Skills (Functional and Technical):

• Strong commercial and financial acumen with a GM-like mindset.
• Deep understanding of oncology customers, treatment pathways, and competitive dynamics.
• Hands-on leader who can move seamlessly between strategy and execution.
• Exceptional stakeholder management, influence, and communication skills.
• High ethical standards with uncompromising compliance orientation.

Why this role is Unique

• First-in-country launch of innovative oncology assets
• Opportunity to build the oncology business from the ground up
• Seat at the Country Leadership Team
• Direct impact on Glenmark’s transformation into an innovation-led oncology player

#J-18808-Ljbffr

2026-02-28 08:09:17